# AN2 Therapeutics, Inc.: Form DEF 14A, filed Apr 22, 2026

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: DEF 14A
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 16:01 ET
- Period: 2026-04-22
- Accession: 0001193125-26-170314
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-170314. Last ingested by Listed: Nov 15, 2026, 04:15 ET. No prices; not investment advice.
